Deborah Weitzman - Cardinal Health Chief Distribution
| CLH Stock | EUR 111.45 2.30 2.02% |
Insider
Deborah Weitzman is Chief Distribution of Cardinal Health
| Phone | 614 757 5000 |
| Web | https://www.cardinalhealth.com |
Deborah Weitzman Latest Insider Activity
Tracking and analyzing the buying and selling activities of Deborah Weitzman against Cardinal Health stock is an integral part of due diligence when investing in Cardinal Health. Deborah Weitzman insider activity provides valuable insight into whether Cardinal Health is net buyers or sellers over its current business cycle. Note, Cardinal Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Cardinal Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Deborah Weitzman over a year ago Acquisition by Deborah Weitzman of 12760 shares of Cardinal Health subject to Rule 16b-3 |
Cardinal Health Management Efficiency
The company has return on total asset (ROA) of 0.0223 % which means that it generated a profit of $0.0223 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.7132) %, meaning that it generated substantial loss on money invested by shareholders. Cardinal Health's management efficiency ratios could be used to measure how well Cardinal Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Steven Humphreys | Identiv | 62 | |
| Edward Kirnbauer | Identiv | 58 | |
| Ravi Mallela | NMI Holdings | 53 | |
| Shui ACS | Shanghai Pharmaceuticals Holdin | 46 | |
| Min Tang | Origin Agritech | 61 | |
| Yaohua Zhang | Shanghai Pharmaceuticals Holdin | 45 | |
| Jan Wicke | Talanx AG | 55 | |
| Gengchen Han | Origin Agritech | 58 | |
| Geoffery Merszei | Origin Agritech | 68 | |
| Robert Smith | NMI Holdings | 53 | |
| Haoliang Gu | Shanghai Pharmaceuticals Holdin | 57 | |
| Yongzhong Li | Shanghai Pharmaceuticals Holdin | 53 | |
| Shuangjun Xu | Sinopharm Group Co | 54 | |
| Erik Fallstrom | SIVERS SEMICONDUCTORS AB | 56 | |
| Dag Sigurd | SIVERS SEMICONDUCTORS AB | 73 | |
| Norman Fitzgerald | NMI Holdings | 56 | |
| Erik Wiklund | SIVERS SEMICONDUCTORS AB | 49 | |
| An Li | Shanghai Pharmaceuticals Holdin | 57 | |
| Sven Pettersson | SIVERS SEMICONDUCTORS AB | 60 | |
| Jun Zhou | Shanghai Pharmaceuticals Holdin | 50 | |
| Steve Dunlap | Identiv | N/A | |
Management Performance
| Return On Equity | -1.71 | |||
| Return On Asset | 0.0223 |
Cardinal Health Leadership Team
Elected by the shareholders, the Cardinal Health's board of directors comprises two types of representatives: Cardinal Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cardinal. The board's role is to monitor Cardinal Health's management team and ensure that shareholders' interests are well served. Cardinal Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cardinal Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ola Snow, Chief Officer | ||
| Patricia English, VP CFO | ||
| Kevin Moran, VP Relations | ||
| Jessica Mayer, Chief Officer | ||
| Mary Scherer, VP Officer | ||
| Craig Cowman, Ex Services | ||
| Deborah Weitzman, Chief Distribution | ||
| Jason Hollar, CEO Director | ||
| Stephen Mason, Chief Segment | ||
| Michelle Greene, Exec Services |
Cardinal Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cardinal Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.71 | |||
| Return On Asset | 0.0223 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 20.94 B | |||
| Shares Outstanding | 257.64 M | |||
| Shares Owned By Insiders | 0.39 % | |||
| Shares Owned By Institutions | 90.36 % | |||
| Price To Earning | 10.35 X | |||
| Price To Book | 15.45 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Cardinal Stock
When determining whether Cardinal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardinal Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardinal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardinal Health Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardinal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Cardinal Stock please use our How to Invest in Cardinal Health guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.